Loading
Latest filing published 31 Jul 2026 for BetterLife Pharma Inc., €62k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Ahmad Doroudian in BetterLife Pharma Inc. Over a trading history stretching from 13 June 2026 to 28 July 2026, the count stands at 5 filings.
Every open-market trade on record is a purchase: 2 purchases worth €3,393, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 option exercise.
On 31 July 2026 came the latest disclosure, a transaction for €62k in BetterLife Pharma Inc. The latest purchase dates back some time: it was published 114 days ago, on 25 June 2026. The median gap between a trade and its publication by SEDI is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations